Jinwon Life Sciences announced on the 6th that it has decided to conduct a third-party allotment paid-in capital increase worth 2.469 billion KRW to raise operating funds. The newly issued shares consist of 722,218 common shares, with an issue price of 3,420 KRW per share.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
